Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
investorenquiries@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
Cancer Therapeutics Research
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Podcast Episode 18: Dr Kim Agnew, PharmAust
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Podcast Episode 18: Dr Kim Agnew, PharmAust
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Top 20 Shareholders

  • Top 20 Shareholders

Top 20 Shareholders April 2023

30/04/2023

Top 20 Shareholders March 2023

31/03/2023

Top 20 Shareholders December 2022

01/01/2023

Top 20 Shareholders November 2022

01/12/2022

Top 20 Shareholders October 2022

01/11/2022

Top 20 Shareholders

30/09/2022

Top 20 Shareholders

01/08/2022

July 1, Top 20 Shareholders

01/07/2022

June 1, Top 20 Shareholders

01/06/2022

May 1, Top 20 Shareholders

01/05/2022

April 1, Top 20 Shareholders

01/04/2022

March 1, Top 20 Shareholders

01/03/2022

February 1, Top 20 Shareholders

01/02/2022

January 1, Top 20 Shareholders

01/01/2022

December 1, Top 20 Shareholders

01/12/2021

September 30, Top 20 Shareholders

01/10/2021

August 31, Top 20 Shareholders

01/09/2021

July 31, Top 20 Shareholders

01/08/2021

June 30, Top 20 Shareholders

01/07/2021

May 31, Top 20 Shareholders

01/06/2021

April 30, Top 20 Shareholders

01/05/2021

March 31, Top 20 Shareholders

01/04/2021

February 28, Top 20 Shareholders

01/03/2021

January 31, Top 20 Shareholders

01/02/2021

December 31, Top 20 Shareholders

04/01/2021

November 30, Top 20 Shareholders

01/12/2020

October 31, Top 20 Shareholders

02/11/2020

September 30, Top 20 Shareholders

01/10/2020

August 31, Top 20 Shareholders

01/09/2020

July 31, Top 20 Shareholders

01/08/2020

June 30, Top 20 Shareholders

01/07/2020

May 31, Top 20 Shareholders

01/06/2020

April 30, Top 20 Shareholders

30/04/2020

31 March, Top 20 Shareholders

31/03/2020

29 February, Top 20 Shareholders

29/02/2020

29 November, Top 20 Shareholders

02/12/2019

30 August 2019 Top 20 Shareholders

02/09/2019

31 July 2019 Top 20 Shareholders

31/07/2019

Top 20 Shareholders, 5 July 2019

05/07/2019

Top 20 Shareholders, 31 May 2019

03/06/2019

30 April, Top 20 Shareholders

06/05/2019

Top 20 Shareholders, March 2019

27/03/2019

Top 20 Shareholders, March 1

01/03/2019

Top 20 Shareholders January 2019

06/02/2019

Top 20 Shareholders 30th December 2018

07/01/2019

Top 20 Shareholders 31st October 2018

06/11/2018

Top 20 Shareholders October 2018

05/10/2018

Top 20 Shareholders September 2018

24/09/2018

Top 20 Shareholders August 2018

17/08/2018

Top 20 Shareholders July 2018

13/07/2018

Top 20 Shareholders June 2018

10/06/2018

Top 20 Shareholders April 2018

27/04/2018

Top 20 Shareholders Feb 2018

26/02/2018
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER


Facebook
Facebook
fb-share-icon
Twitter
YouTube

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
4 Sep

Great spread on Louie the Beagle in @AustVetMag Australian Veterinarian Magazine - Spring Issue

https://simplebooklet.com/theaustralianveterinarianmagazine_spring_2023_issue21

Reply on Twitter 1698509346102010223 Retweet on Twitter 1698509346102010223 2 Like on Twitter 1698509346102010223 9 Twitter 1698509346102010223
pharmaust PharmAust @pharmaust ·
2 Sep

PharmAust CEO Dr Michael Thurn spoke with @Biotech_Buzz from @StocksDownUnder and @PSR_Insights about the clinical success with our flagship drug, Monepantel (MPL)

🎥 https://youtu.be/oCfvzseRDxQ?si=iBZu_GMBIg5oSiMX

Reply on Twitter 1697769500807176530 Retweet on Twitter 1697769500807176530 2 Like on Twitter 1697769500807176530 13 Twitter 1697769500807176530
pharmaust PharmAust @pharmaust ·
29 Aug

New CEO to take the helm as PharmAust progresses clinical studies

Reply on Twitter 1696342181496443106 Retweet on Twitter 1696342181496443106 2 Like on Twitter 1696342181496443106 7 Twitter 1696342181496443106
Load More

Copyright © 2023 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top